INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. on January 6, 2026, covering events that occurred on December 30, 2025. The filing details significant changes to the company's executive leadership structure intended to support its growth strategy.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and personnel changes.
Material Changes
- Appointment of Chief Financial Officer: Terah Krigsvold was appointed CFO effective December 30, 2025. She has served as the company's controller since December 2020.
- Role Change for Former CFO: Andrea Goren resigned as CFO and was appointed Chief Business Officer effective December 30, 2025. The resignation was not due to any disagreement with the company.
- Compensation Adjustments:
- Ms. Krigsvold will receive an annual base salary of $250,000, with eligibility for a performance bonus of up to 50% of base salary and stock grants under the 2019 Stock Incentive Plan.
- Mr. Goren's employment agreement was amended to reflect a base salary of $250,000, with eligibility for a performance bonus of up to 50% of base salary and stock grants under the 2019 Stock Incentive Plan.
Outlook, Risks, and Management Commentary
Management stated that the leadership realignment is designed to support the company's growth strategy. The filing explicitly notes that Mr. Goren's departure from the CFO role was not caused by disagreements regarding operations, policies, or practices. No specific financial guidance, risks, or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the full terms of the "Krigsvold Amended and Restated Employment Agreement" (Exhibit 10.1) and the "Goren Amendment" (Exhibit 10.2) for details on vesting schedules and termination provisions.
- Review the press release dated December 30, 2025 (Exhibit 99.1) for additional strategic context regarding the leadership changes.
- Confirm the impact of these personnel changes on the company's financial reporting and internal controls in subsequent filings.